Clinical Pharmacology of Cannabis in Relation to its Social Use
One of the peculiarities of the problem of determining the potential for social use for drugs with properties like cannabis is that the issue has usually been settled empirically by users before the problem is anticipated by the rest of us. As most of the agents in this class, which might also include the hallucinogens, are not used therapeutically, except in an experimental way, and none seem to be destined for the usual marketplace, no systematic efforts have been taken to determine ways to anticipate the problem of their potential for social use, as in the case of narcotic analgesics.
Unable to display preview. Download preview PDF.
- Cannabis. A report of the Commission of Inquiry into the Non-Medical Use of Drugs. Information Canada, Ottawa, 1972. Catalogue No. H 1–5370 /4.Google Scholar
- Clark, L. D., Hughes, R., Nakashima, E. N.: Behavioral effects of marihuana. Experimental studies. Arch. gen. Psychiat. 23, 193–198 (1970).Google Scholar
- Kopell, B. S., Tinklenberg, J. R., Hollister, L. E.: Contingent negative variation amplitudes: Marihuana and ethanol. Arch. gen. Psychiat. (in press).Google Scholar
- Marihuana and Health. Second Ann. Report to Congress, pp. 75–724. Washington, D. C.: U.S. Government Printing Office 1972.Google Scholar
- Mayor’s Committee on Marihuana. The Marihuana Problem in the City of New York — Sociological, Medical, Psychological and Pharmacological Studies. Lancaster, Pa.: Cattell Press 1944.Google Scholar
- Moran, L. J.: Repetitive psychometric measures. Austin: University of Texas 1959.Google Scholar
- Singer, A. J. (Ed.): Marihuana: Chemistry, Pharmacology and Patterns of Social Use. Ann. N.Y. Acad. Sci. 191 (1971).Google Scholar
- Tennant, F. S., Jr., Groesbeck, C. J.: Psychiatric effects of hashish. Arch. gen. Psychiat. 27, 133–136 (1972).Google Scholar